A case of severe cardiomyopathy due to COVID-induced myocarditis, completely resolved after colchicine and immunoglobulin therapy
Coronavirus 19 (COVID-19) is well known for causing acute respiratory distress syndrome. Among other systemic complications, myocarditis is a frequently reported presentation as well as complication. One systematic review reported a 14% mortality rate in patients with COVID-19 myocarditis. Endomyoca...
Main Authors: | Su Khine, Srujan Edupuganti, Ghassan Bachuwa |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2023-08-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/3877 |
Similar Items
-
Colchicine Is a Weapon for Managing the Heart Disease Among Interstitial Lung Disease With Viral Infection: Have We Found the Holy Grail?
by: Jun-Jun Yeh, et al.
Published: (2022-06-01) -
Three Myocardial Diseases in One Heart: Arrhythmogenic Right Ventricular Cardiomyopathy, Left Ventricular Noncompaction and Myocarditis
by: Yulia Lutokhina, et al.
Published: (2021-02-01) -
Myocarditis Complicated by Complete Atrioventricular Block: Nine Years' Experience in a Medical Center
by: Shao-Ju Chien, et al.
Published: (2008-12-01) -
Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy
by: Katharina Knoll, et al.
Published: (2023-07-01) -
Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment
by: Felicitas Escher, et al.
Published: (2015-12-01)